Literature DB >> 30194159

Prognostic Value of Serum Creatinine Levels in Patients with Epithelial Ovarian Cancer.

Judith Lafleur1,2, Katrin Hefler-Frischmuth3, Christoph Grimm4, Richard Schwameis1,4, Lisa Gensthaler4, Elisabeth Reiser4, Lukas A Hefler5,2.   

Abstract

AIM: To evaluate preoperative serum creatinine level as a prognostic parameter in patients with primary epithelial ovarian cancer (EOC). PATIENTS AND METHODS: In a retrospective cohort study, serum levels of creatinine were evaluated in 498 patients with EOC. Data were extracted from our prospectively maintained database. Results were correlated with clinicopathological parameters and patient survival.
RESULTS: The mean pre-therapeutic serum creatinine level in patients with EOC was 0.84±0.40 mg/dI. A serum creatinine level of 1.2 mg/dl or higher was found in 22 (4.4%) patients and associated with poor survival. In a multivariate logistic regression analysis, the serum creatinine level was a significant independent prognostic parameter of overall survival.
CONCLUSION: The preoperative serum level of creatinine may be useful as an additional independent prognostic parameter in patients with EOC. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Ovarian cancer; creatinine; prognosis

Mesh:

Substances:

Year:  2018        PMID: 30194159     DOI: 10.21873/anticanres.12834

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Assessment of Serum Urea, Creatinine and Uric Acid in Oral Cancer.

Authors:  Ana Caruntu; Liliana Moraru; Diana Alina Ciubotaru; Cristiana Tanase; Cristian Scheau; Constantin Caruntu
Journal:  J Clin Med       Date:  2022-06-16       Impact factor: 4.964

2.  The Pretreatment Controlling Nutritional Status Score in Ovarian Cancer: Influence on Prognosis, Surgical Outcome, and Postoperative Complication Rate.

Authors:  Christine Bekos; Christoph Grimm; Lisa Gensthaler; Thomas Bartl; Alexander Reinthaller; Richard Schwameis; Stephan Polterauer
Journal:  Geburtshilfe Frauenheilkd       Date:  2022-01-10       Impact factor: 2.915

3.  Association Between Serum Creatinine Concentrations and Overall Survival in Patients With Colorectal Cancer: A Multi-Center Cohort Study.

Authors:  Ming Yang; Qi Zhang; Guo-Tian Ruan; Meng Tang; Xi Zhang; Meng-Meng Song; Xiao-Wei Zhang; Kang-Ping Zhang; Yi-Zhong Ge; Han-Ping Shi
Journal:  Front Oncol       Date:  2021-10-07       Impact factor: 6.244

4.  Nomogram Incorporating Preoperative Testing Markers for the prediction of Early Recurrence for Colorectal Liver Metastases with Neoadjuvant Chemotherapy followed by Hepatectomy.

Authors:  Qichen Chen; Yizhou Zhang; Xingchen Li; Zhen Huang; Hong Zhao; Jianqiang Cai
Journal:  J Cancer       Date:  2022-03-14       Impact factor: 4.207

5.  Could outcomes of intracranial aneurysms be better predict using serum creatinine and glomerular filtration rate?

Authors:  Nícollas Nunes Rabelo; Leonardo Zumerkorn Pipek; Rafaela Farias Vidigal Nascimento; João Paulo Mota Telles; Natalia Camargo Barbato; Antônio Carlos Samaia da Silva Coelho; Guilherme Bitencourt Barbosa; Marcia Harumy Yoshikawa; Manoel Jacobsen Teixeira; Eberval Gadelha Figueiredo
Journal:  Acta Cir Bras       Date:  2022-04-08       Impact factor: 1.388

6.  Short- (30-90 days) and mid-term (1-3 years) outcomes and prognostic factors of patients with esophageal cancer undergoing surgical treatments.

Authors:  Meng-Kun Shi; Yun-Qing Mei; Jia-Lun Shi
Journal:  World J Clin Cases       Date:  2022-08-06       Impact factor: 1.534

7.  Role of Serum Creatinine Levels in Prognostic Risk Stratification of Prostate Cancer Patients.

Authors:  Xingbo Gu; Jiaojiao Wu; Xuefeidan Liu; Yun Hong; Yaoxi Wu; Ye Tian
Journal:  Med Sci Monit       Date:  2022-07-22

8.  Cancer Alters the Metabolic Fingerprint of Extracellular Vesicles.

Authors:  Mari Palviainen; Kirsi Laukkanen; Zeynep Tavukcuoglu; Vidya Velagapudi; Olli Kärkkäinen; Kati Hanhineva; Seppo Auriola; Annamari Ranki; Pia Siljander
Journal:  Cancers (Basel)       Date:  2020-11-06       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.